BR112013011607A2 - ingredientes cristalinos farmaceuticamente ativos - Google Patents
ingredientes cristalinos farmaceuticamente ativosInfo
- Publication number
- BR112013011607A2 BR112013011607A2 BR112013011607A BR112013011607A BR112013011607A2 BR 112013011607 A2 BR112013011607 A2 BR 112013011607A2 BR 112013011607 A BR112013011607 A BR 112013011607A BR 112013011607 A BR112013011607 A BR 112013011607A BR 112013011607 A2 BR112013011607 A2 BR 112013011607A2
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutically active
- active crystalline
- crystalline ingredients
- ingredients
- pharmaceutically
- Prior art date
Links
- 239000004615 ingredient Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU1000616A HU230737B1 (hu) | 2010-11-16 | 2010-11-16 | Eljárás rosuvastatin só előállítására |
PCT/HU2011/000107 WO2012066365A2 (en) | 2010-11-16 | 2011-11-16 | Crystalline pharmaceutically active ingredients |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112013011607A2 true BR112013011607A2 (pt) | 2016-08-09 |
Family
ID=89990067
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112013011607A BR112013011607A2 (pt) | 2010-11-16 | 2011-11-16 | ingredientes cristalinos farmaceuticamente ativos |
Country Status (14)
Country | Link |
---|---|
US (1) | US9321733B2 (pt) |
EP (1) | EP2640710A2 (pt) |
JP (1) | JP2013542977A (pt) |
CN (1) | CN103328450A (pt) |
AU (1) | AU2011330868A1 (pt) |
BR (1) | BR112013011607A2 (pt) |
CA (1) | CA2816952A1 (pt) |
EA (1) | EA024416B1 (pt) |
HU (1) | HU230737B1 (pt) |
IL (1) | IL226154A0 (pt) |
MX (1) | MX2013005426A (pt) |
UA (1) | UA109560C2 (pt) |
WO (1) | WO2012066365A2 (pt) |
ZA (1) | ZA201303371B (pt) |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI94339C (fi) | 1989-07-21 | 1995-08-25 | Warner Lambert Co | Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi |
JP2648897B2 (ja) | 1991-07-01 | 1997-09-03 | 塩野義製薬株式会社 | ピリミジン誘導体 |
BR9609872A (pt) | 1995-07-17 | 1999-03-23 | Warner Lambert Co | Hemi sal de cálcio de ácido (R-(R*R*)]-2-(4-fluorfenil-)-beta delta-diidróxi-5-(1-metiletil)-3-fenil-4- [(fenilamino) carbonil]-1H- pirrol-1heptanóico (atorvasta-tina)c ristalino |
GB0003305D0 (en) | 2000-02-15 | 2000-04-05 | Zeneca Ltd | Pyrimidine derivatives |
UY28501A1 (es) | 2003-09-10 | 2005-04-29 | Astrazeneca Uk Ltd | Compuestos químicos |
CA2546701C (en) | 2003-11-24 | 2010-07-27 | Teva Pharmaceutical Industries Ltd. | Crystalline ammonium salts of rosuvastatin |
WO2005077917A1 (en) | 2004-01-19 | 2005-08-25 | Ranbaxy Laboratories Limited | Amorphous salts of rosuvastatin |
WO2006079611A1 (en) | 2005-01-31 | 2006-08-03 | Ciba Specialty Chemicals Holding Inc. | Crystalline forms of rosuvastatin calcium salt |
JP2009530232A (ja) | 2006-01-30 | 2009-08-27 | カディラ・ヘルスケア・リミテッド | ロスバスタチンカリウムの製造方法 |
HU227696B1 (en) * | 2006-04-13 | 2011-12-28 | Egyt Gyogyszervegyeszeti Gyar | Zinc salt of rosuvastatin, process for its preparation and pharmaceutical compositions containing it |
WO2008015563A2 (en) * | 2006-08-04 | 2008-02-07 | Glenmark Pharmaceuticals Limited | Salts of rosuvastatin and processes for their preparation |
JP2008539278A (ja) | 2006-09-18 | 2008-11-13 | テバ ファーマシューティカル インダストリーズ リミティド | 結晶性ロスバスタチンカルシウム |
WO2008038132A1 (en) | 2006-09-28 | 2008-04-03 | Aurobindo Pharma Limited | Crystalline diamine salts of rosuvastatin |
HU230981B1 (hu) * | 2007-10-12 | 2019-08-28 | Egis Gyógyszergyár Nyilvánosan Működő Részvénytársaság | Eljárás rosuvastatin só előállítására |
HU230637B1 (hu) * | 2007-10-12 | 2017-05-29 | Egis Gyógyszergyár Nyilvánosan Működő Részvénytársaság | Eljárás rosuvastatin intermedierek előállítására |
MX2011007478A (es) * | 2009-01-15 | 2011-09-15 | Sag Egis Gyogyszergyar Nylvanosan Muekoedoe Reszvenytarsa | Proceso para la preparacion de sales de rosuvastatina. |
US9023838B2 (en) * | 2009-07-24 | 2015-05-05 | Egis Gyogyszergyar Nyilvanosan Muekoedoe | Crystalline form I rosuvastatin zinc salt |
-
2010
- 2010-11-16 HU HU1000616A patent/HU230737B1/hu unknown
-
2011
- 2011-11-16 CN CN2011800553625A patent/CN103328450A/zh active Pending
- 2011-11-16 CA CA2816952A patent/CA2816952A1/en not_active Abandoned
- 2011-11-16 US US13/885,509 patent/US9321733B2/en not_active Expired - Fee Related
- 2011-11-16 AU AU2011330868A patent/AU2011330868A1/en not_active Abandoned
- 2011-11-16 UA UAA201307540A patent/UA109560C2/ru unknown
- 2011-11-16 JP JP2013539345A patent/JP2013542977A/ja active Pending
- 2011-11-16 MX MX2013005426A patent/MX2013005426A/es not_active Application Discontinuation
- 2011-11-16 BR BR112013011607A patent/BR112013011607A2/pt not_active IP Right Cessation
- 2011-11-16 WO PCT/HU2011/000107 patent/WO2012066365A2/en active Application Filing
- 2011-11-16 EP EP11827789.6A patent/EP2640710A2/en not_active Ceased
- 2011-11-16 EA EA201390700A patent/EA024416B1/ru not_active IP Right Cessation
-
2013
- 2013-05-05 IL IL226154A patent/IL226154A0/en unknown
- 2013-05-09 ZA ZA2013/03371A patent/ZA201303371B/en unknown
Also Published As
Publication number | Publication date |
---|---|
EA201390700A1 (ru) | 2013-10-30 |
EA024416B1 (ru) | 2016-09-30 |
WO2012066365A3 (en) | 2012-08-02 |
JP2013542977A (ja) | 2013-11-28 |
ZA201303371B (en) | 2014-07-30 |
CN103328450A (zh) | 2013-09-25 |
MX2013005426A (es) | 2013-07-05 |
HUP1000616A2 (en) | 2012-06-28 |
AU2011330868A1 (en) | 2013-06-06 |
WO2012066365A2 (en) | 2012-05-24 |
UA109560C2 (ru) | 2015-09-10 |
HU1000616D0 (en) | 2011-01-28 |
HU230737B1 (hu) | 2018-01-29 |
IL226154A0 (en) | 2013-06-27 |
CA2816952A1 (en) | 2012-05-24 |
US20130296353A1 (en) | 2013-11-07 |
EP2640710A2 (en) | 2013-09-25 |
US9321733B2 (en) | 2016-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SMT201700008B (it) | Composizione farmaceutica | |
CO6811868A2 (es) | Combinaciones de principios activos | |
HK1185879A1 (zh) | 作為 抑制劑的藥物活性化合物 | |
DK3284467T3 (da) | Nikotinholdige farmaceutiske sammensætninger | |
BR112013002845A2 (pt) | combinação de susbtâncias ativas | |
DK3222272T3 (da) | Farmaceutisk sammensætning med carbetocin | |
FI20105860A (fi) | Aktiivinen paikannusjärjestelmä | |
GT201200303A (es) | Formulaciones farmacéuticas | |
EE201300005A (et) | Ravimkoostis | |
SMT201600004B (it) | Coniugato cristallino di naloxolo-peg | |
GB201004964D0 (en) | Active target | |
DK2635269T3 (da) | Kombinationspræparat | |
BR112013002589A2 (pt) | valsatana altamente cristalina | |
BR112012029461A2 (pt) | composição farmacêutica contendo solifenacina | |
EP2864328B8 (en) | Pharmaceutically active compounds | |
SI2474529T1 (sl) | Kristalne oblike aktivne farmacevtske učinkovine | |
BR112013020866A2 (pt) | combinações de compostos ativos | |
BR112013011455A2 (pt) | microbiocidas | |
EP2770561A4 (en) | NEGATIVE ELECTRODE ACTIVE SUBSTANCE FOR USE IN AN ELECTRICAL DEVICE | |
GB201001203D0 (en) | Use of pharmaceutically active compounds | |
BR112013011607A2 (pt) | ingredientes cristalinos farmaceuticamente ativos | |
FR2967069B3 (fr) | Formulations | |
DK2598472T3 (da) | Formuleringer | |
NO20100920A1 (no) | Barnestol | |
BR112012029887A2 (pt) | composição farmacêutica |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |